The Effect of 12-week Circuit Training on Insulin Sensitivity and Endothelial Function in Women With Insulin Resistance

September 22, 2025 updated by: Marzena Ratajczak, Poznan University of Physical Education

The Effect of 12-week Circuit Training (Combination of Strength and Endurance Exercises) on Insulin Sensitivity and Vascular Endothelial Function in Women With Insulin Resistance

During the last 10 years many studies concerning the impact of physical training on whole-body insulin sensitivity have been published, but there is a lack of an extended investigation on the potential clinical benefits of novel circuit training-based on strength and endurance exercises-relating to the optimization of insulin sensitivity and vascular endothelial function. It is of interest to precisely determine the physiological and biochemical effects of circuit training. An important aspect of the planned research will be the analysis of the effects of physical training on the released during muscle contraction myokines capable of modulating various metabolic processes. We hypothesized that in studied participants 12 weeks of the novel form of training would result in improving insulin sensitivity and vascular endothelial function mainly via myokines released by contracting skeletal muscles.

The following questions will be asked: (1) whether the 12-week circuit training (combined strength and endurance exercises) performed by women with insulin resistance, improves insulin sensitivity, carbohydrate and lipid metabolism and promotes the efficiency of endothelial defense mechanisms? (2) whether the 12-week circuit training (combined of strength and endurance exercises) changes the concentrations of transcription factors regulating lipid and carbohydrate metabolism or the synthesis and/or secretion of myokines and adipokines in women with insulin resistance? (3) whether the 12-week strength training, interspersed with bouts of endurance exercise has a positive effect on cytokine profile? (4) whether there is a relationship between changes in body composition, HOMA-IR, and the level of myokines caused by physical training? (5) whether the 12-week circuit training reduces low back pain symptoms, plantar stifness and improve functioning of the patient in everyday life? A group of 80 women, aged 25 to 45 years, with diagnosed insulin resistance will participate in the planned study. Participants will be enrolled in the research program based on medical qualification. Before the intervention all women will have venous blood collected to determine fasting glucose, hemoglobin glycosylated (HbA1C) and insulin levels and insulin resistance by the homeostasis model assessment of insulin resistance (HOMA-IR) will be calculated. The inclusion criteria will be as follows: (1) women, age: 25-45 years, menstruating, (2) BMI 18,5-29,9 kg/m2, (3) insulin resistance based on HOMA-IR (cut-off point 2.5), (4) HbA1C ≤ 6.5%, (5) not contraindicated to physical activity. Participants meeting the inclusion criteria will be randomly divided into two groups. The first group of women will undergo circuit training, consisting of exercises performed on 7 machines arranged in a circuit. Thanks to the use of adequate software the machines will automatically adjust their parameters, such as seat height or resistance to the exercising person, and the training progress will be individually monitored. The planned training will last for 3 months, during which the patients will exercise 3 times a week for 30 minutes (2 circuits will be done during each session). The planned duration of the training session will be controlled (one minute for strength exercises, four minutes for endurance exercises and a 30-second break between each exercise). In the training group, one-repetition maximum exercise test (1RM) will be performed to determine the appropriate training load and later after the program to verify the increase in muscle strength. The range of maximum heart rate (HRmax) will also be determined in all exercising women. The second group of women, who will be asked to maintain their current level of physical activity and their diet for a period of 3 months will serve as a control group. Before and after the training program in all participants of the study pulse wave velocity, anthropometric parameters and body composition will be assessed. Concurrently venous blood will be taken to determine biochemical indicators related to carbohydrate and lipid metabolism, insulin resistance, vascular endothelium function, inflammation and adipocytokines and myokines. In both groups of women, the questioners concerning dietary intake and the level of daily physical activity will be administered.

Results will be subjected to analysis involving descriptive, and advanced statistic method among them analysis of correlations, regression, variance and cluster analysis. All calculations and statistics will be performed using TIBCO Statistica 13.3 software (TIBCO).

Study Overview

Detailed Description

The training program will be performed on 7 machinesin a circuit. The devices will be controlled by a pre-programmed chip card, so that they will automatically adjust their parameters, such as seat height or resistance to the patient, and it will be possible to monitor the training progress of exercising women and their presence during training. Only two people will be allowed in the room during the training. The planned duration of the exercises will be controlled (one minute for strength exercises, four minutes for endurance exercisesand a 30-second break between each exercise) and for each trainee the load will be dosed using the electronic resistance motor system. Exercises in the training program are planned in such a way that the different muscle groups of women exercising are loaded alternately, which will ensure comprehensive training of the whole body. The range of movement, exercise duration and breaks will be controlled automatically by the system and the software of the devices and will not require additional training attention.

In the training group, one-repetition maximum exercise test (1RM) will be performed to determine the appropriate training load and later after the program to verify the increase in muscle strength.

The HR max range will be determined for exercising women by the indirect method using the formula: training HR = 220 -subject age.

The characteristics of exercises in the circuit:

  1. The training circuit starts with an exercise on a cycloergometer -"bike", which lasts 4 minutes.
  2. The second exercise -"abdominal crunch", shapes the strength of the abdominal muscles and together with exercise number six, it not only improves muscle strength parameters, but also shapes balance and maintains the correct position of the body.
  3. The third exercisein a circuit-"leg curl", shapes the muscular strength of the back of the thigh (biceps femoris muscleand muscles adjacent to it).
  4. The fourth exercise -"lat pulldown", trains the strength of the latissimus dorsi muscle, shoulder girdle muscles and upper chest. In addition to improving the strength and function of the muscles mentioned above, the exercise also perfectly stimulates the auxiliary respiratory muscles.
  5. Fifth exercise -"crosswalker".This exercise trainsmost of the body's muscles, itlasts 4 minutes and, like training on a cycloergometer, primarily shapes thephysical capacity.
  6. The sixth exercise -"back extension"trains the strength of the abdominal muscles, erector spinae and other muscles of a back.
  7. The seventh exercise -"legabductor", the last in the series, is an exercise that shapes the gluteal muscles, as well as hip adductor and abductor muscles. This exercise fulfills the function of shaping strength and securing the hip joint, by training the muscle parts less frequently used in everyday life, the more difficult to be kept fit as the years go by and the level of physical activity decreases.

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Poznan, Poland, 61-871
        • Poznan University of Physical Education

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • women,
  • age: 25-45years,
  • menstruating,
  • BMI 18,5-29,9 kg/m2,
  • insulin resistance based on HOMA -IR (cut-off point 2.5),
  • not contraindicated to physical activity.

Exclusion Criteria:

  • type 1 and 2 diabetes,
  • poorly controlled hypertension (mean SBP >140mmHg and/or mean DBP >90mmHg) over the last month and/or need to modify the pharmacological treatment,
  • obesity: BMI > 30 kg/m2,
  • lipid disorders requiring implementation of pharmacological treatment in the last 3 months before or during observation,
  • a positive history of ischemic heart disease, carotid atherosclerosis and / or lower limb atherosclerosis,
  • clinically significant arrhythmias or conduction disorders,
  • chronickidney disease,
  • clinically significant liver dysfunction,
  • acute or chronic, clinically manifest inflammatory process,
  • an acute infection in the last month,
  • cancer,
  • taking dietary supplements within a month before inclusion and during observation,
  • taking medication that could interfere with the results of the tests,
  • other conditions that may pose any risk to the patient during the observation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
40 women with insulin resistance aged 25-45, BMI 18,5-29,9 will perform, for a period of 3 months, 3 times a week, strength training, interspersed with bouts of endurance exercise carried out on circuit machines integrated with the Milon computer software.
The intervention will last 3 months, exercises will take place 3 times a week and will consist of strength exercises, interspersed with bouts of endurance exercise carried out on circuit machines integrated with the Milon computer software for a total of 30 minutes per session.
Other Names:
  • Circuit training on machines integrated with the Milon computer software
No Intervention: Control
40 women with insulin resistance aged 25-45, BMI 18,5-29,9 will be asked to maintain their current level of physical activity and their diet for a period of 3 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Homeostasis model assessment of insulin resistance (HOMA-IR)
Time Frame: pre-intervention
pre-intervention
Homeostasis model assessment of insulin resistance (HOMA-IR)
Time Frame: 48 hours after the intervention
48 hours after the intervention
HbA1C [mmol/mol]
Time Frame: pre-intervention
ELISA
pre-intervention
HbA1C [mmol/mol]
Time Frame: 48 hours after the intervention
ELISA
48 hours after the intervention
Insuline [mU/ml]
Time Frame: pre-intervention
Radioimmunoassay
pre-intervention
Insuline [mU/ml]
Time Frame: 48 hours after the intervention
Radioimmunoassay
48 hours after the intervention
Systolic and diastolic blood pressure [mmHg]
Time Frame: pre-intervention
pre-intervention
Systolic and diastolic blood pressure [mmHg]
Time Frame: 48 hours after the intervention
48 hours after the intervention
Pulse wave velocity (PWV) [m/s]
Time Frame: pre-intervention
PWV will be performed using the SphygmoCor Px (Atcor Medical Blood Pressure Analysis System, Sydney, Australia.
pre-intervention
Pulse wave velocity (PWV) [m/s]
Time Frame: 48 hours after the intervention
PWV will be performed using the SphygmoCor Px (Atcor Medical Blood Pressure Analysis System, Sydney, Australia.
48 hours after the intervention
Glucose, Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) [mmol/l]
Time Frame: pre-intervention
Dimension Flex Reagent Cartridge
pre-intervention
Glucose, Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) [mmol/l]
Time Frame: 48 hours after the intervention
Dimension Flex Reagent Cartridge
48 hours after the intervention
Irisin, Visfatin, Retinol-binding protein 4 (RBP-4) [pg/ml]
Time Frame: pre-intervention
ELISA
pre-intervention
Irisin, Visfatin, Retinol-binding protein 4 (RBP-4) [pg/ml]
Time Frame: 48 hours after the intervention
ELISA
48 hours after the intervention
Apelin [ng/ml]
Time Frame: pre-intervention
ELISA
pre-intervention
Apelin [ng/ml]
Time Frame: 48 hours after the intervention
ELISA
48 hours after the intervention
C Reactive Protein (hsCRP) [mg/l]
Time Frame: pre-intervention
ELISA
pre-intervention
C Reactive Protein (hsCRP) [mg/l]
Time Frame: 48 hours after the intervention
ELISA
48 hours after the intervention
Interleukin-6 (IL-6), Interleukin-10 (IL-10) [pg/ml]
Time Frame: pre-intervention
ELISA
pre-intervention
Interleukin-6 (IL-6), Interleukin-10 (IL-10) [pg/ml]
Time Frame: 48 hours after the intervention
ELISA
48 hours after the intervention
Endothelial nitric oxide synthase (eNOS) [ng/ml]
Time Frame: pre-intervention
ELISA
pre-intervention
Endothelial nitric oxide synthase (eNOS) [ng/ml]
Time Frame: 48 hours after the intervention
ELISA
48 hours after the intervention
Muscle strength [kg]
Time Frame: pre-intervention
Test 1RM will be performed for following groups of muscles: abdominal muscles; back of the thigh (biceps femoris muscle and muscles adjacent to it); latissimus dorsi muscle, shoulder girdle muscles and upper chest; erector spinae and other muscles of a back; gluteal muscles, hip adductor and abductor muscles.
pre-intervention
Muscle strength [kg]
Time Frame: 48 hours after the intervention
Test 1RM will be performed for following groups of muscles: abdominal muscles; back of the thigh (biceps femoris muscle and muscles adjacent to it); latissimus dorsi muscle, shoulder girdle muscles and upper chest; erector spinae and other muscles of a back; gluteal muscles, hip adductor and abductor muscles.
48 hours after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plantar stiffness [N/m]
Time Frame: pre-intervention
Biomechanical properties will be assessed with myotonometer device.
pre-intervention
Plantar stiffness [N/m]
Time Frame: 48 hours after the intervention
Biomechanical properties will be assessed with myotonometer device.
48 hours after the intervention
State of tension of erector spinae muscles [Hz]
Time Frame: pre-intervention
Natural oscillation frequency [Hz], characterizing Tone or Tension will be assessed with myotonometer device.
pre-intervention
State of tension of erector spinae muscles [Hz]
Time Frame: 48 hours after the intervention
Natural oscillation frequency [Hz], characterizing Tone or Tension will be assessed with myotonometer device.
48 hours after the intervention
Low back pain intensity: questionnaire
Time Frame: pre-intervention
Visual analogue scale (VAS) pain intensity questionare (reporting a score on a 10-point scale, the minimum (0) means no pain and the maximum (10) means a worst pain imaginable
pre-intervention
Low back pain intensity: questionnaire
Time Frame: 48 hours after the intervention
Visual analogue scale (VAS) pain intensity questionare (reporting a score on a 10-point scale, the minimum (0) means no pain and the maximum (10) means a worst pain imaginable
48 hours after the intervention
Disability caused by pain in the spine
Time Frame: pre-intervention
Oswestry questionnaire. When completing the questionnaire, the subject answers questions concerning: pain intensity, independence, lifting objects, walking, sitting, standing, sleeping, social life, sexual activity and traveling. The answers to the questions help to classify how limited the functioning of the patient is while performing certain activities. Responses are graded from 0 to 5. The overall score is given on a 0-50 point scale, where the higher the score, the greater the disability.
pre-intervention
Disability caused by pain in the spine
Time Frame: 48 hours after the intervention
Oswestry questionnaire. When completing the questionnaire, the subject answers questions concerning: pain intensity, independence, lifting objects, walking, sitting, standing, sleeping, social life, sexual activity and traveling. The answers to the questions help to classify how limited the functioning of the patient is while performing certain activities. Responses are graded from 0 to 5. The overall score is given on a 0-50 point scale, where the higher the score, the greater the disability.
48 hours after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 17, 2020

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

August 23, 2020

First Submitted That Met QC Criteria

August 23, 2020

First Posted (Actual)

August 27, 2020

Study Record Updates

Last Update Posted (Estimated)

September 23, 2025

Last Update Submitted That Met QC Criteria

September 22, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insulin Resistance

Clinical Trials on Circuit training (combination of strength and endurance exercises)

Subscribe